ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000264469.1	Ponatinib	Bladder urothelial carcinoma	0.010268968	Resistant
ENSG00000264469.1	Ponatinib	Breast invasive carcinoma	0.024236911	Sensitive